The National Medical Products Administration (NMPA) approved a total of 164 medical devices for marketing in May 2022. The approvals included 109 domestic Class III products, 23 imported Class III products, 30 imported Class II products, and 2 products from “special administrative regions.”
Notable Approvals
Among the approved devices were offerings from multinational companies such as Medtronic’s transcatheter implantable leadless pacing system and Boston Scientific Corporation’s disposable electronic ureteropelvic endoscopic catheter.-Fineline Info & Tech
